Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Pathway to eliminating antibiotic-resistant tuberculosis in the Pacific

Pathway to eliminating antibiotic-resistant tuberculosis in the Pacific

Date time 30 June, 2020
News Type News type Research News
Australian researchers, including from the Centenary Institute have been awarded funding for a major project that aims to eliminate both active and latent tuberculosis (TB) found on Kiribati, an island nation in the central Pacific Ocean. The project will also support multidrug-resistant TB control education and management through the Pacific region.

Australian researchers, including from the Centenary Institute have been awarded funding for a major project that aims to eliminate both active and latent tuberculosis (TB) found on Kiribati, an island nation in the central Pacific Ocean. The project will also support multidrug-resistant TB control education and management through the Pacific region.

Led by Professor Barend Marais of the University of Sydney, Professor Warwick Britton AO, Head of the Centenary Institute’s Tuberculosis Research Program will be a Chief Investigator (CIB) on the project with colleagues from the NHMRC Centre of Research Excellence in Tuberculosis Control.

“A TB hotspot, Kiribati has extremely high rates of tuberculosis. The capital Tarawa, one of the most densely populated areas in the Pacific, has a TB incidence rate among the highest in the world,” said Professor Britton.

“Our project will ensure that every person over the age of 2 will be screened for TB disease or infection in Tarawa with appropriate treatment strategies then implemented. Our integrated project will also provide a pathway towards drug resistant TB prevention and TB elimination  more broadly within the Pacific, through a program of training and mentoring.”

“Overall, this program will be a catalyst in regional TB elimination efforts, helping save lives and overcoming a disease which has devastating impact on communities,” he said.

The Federal Government’s announcement regarding the project funding can be accessed online.

TB is a leading cause of death globally responsible for approximately 1.5 million deaths annually.

Read more about Professor Britton and his research here.

Image Credit: Vladimir Lysenko. https://commons.wikimedia.org/w/index.php?curid=39278217

Themes

  • Inflammation

    Inflammation

Laboratories

  • Britton

People

  • Professor Warwick Britton AO

    Faculty

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Prestigious editorial award for Professor Gorrell

    Professor Mark Gorrell from the Centenary Institute’s Centre for Cancer Innovations has been awarded a Springer Nature Editorial Contribution Award celebrating his outstanding editorial work for the highly respected journal Scientific Reports. The award recognises editorial board members who have made a notable contribution to the journal’s peer-review and publishing processes. Professor Gorrell has served ...
    News Type: Research News
    Date 16 Jun 2025
  • Serena Li, inaugural Chair of Centenary’s ReST Association

    Serena Li, a research assistant at the Centenary Institute, has recently been appointed as the Chair of the newly established ReST (Research Assistants, Support and Technicians) Association.
    News Type: Profiles
    Date 10 Jun 2025
  • Centenary Institute hosts TB research symposium

    The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.
    News Type: Events
    Date 02 Jun 2025
  • New discovery could improve treatment for people with haemophilia A

    Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.
    News Type: Media release
    Date 28 May 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram